• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Oncology

Latest News

Eunice Wang, MD | Image: Roswell Park Comprehensive Cancer Center
Presentation on Menin Inhibitors Strives to Stay Ahead of the Progress

December 15th 2025

Eunice Wang, MD, highlights breakthroughs in menin inhibitors for acute leukemias, showcasing promising combination therapies and addressing treatment challenges at ASH 2025.

FDA approval | Image Credit: Tada Images  - stock.adobe.com
5 Key Oncology FDA Approvals From November

December 12th 2025

FDA approval | Image Credit: Olivier Le Moal - stock.adobe.com
FDA Approves Durvalumab With FLOT Chemotherapy for Resectable Gastric and Gastroesophageal Junction Cancer

November 25th 2025

The approval of selumetinib for adults with neurofibromatosis type 1 adds previous approvals in pediatric patients. | Image credit: BHM - stock.adobe.com
FDA Approves Selumetinib for Adults With Neurofibromatosis Type 1

November 20th 2025

The new recommendations are the result of collaboration between several global pediatric soft tissue sarcoma groups. | Image credit: ColoredLights - stock.adobe.com
Consensus Document Outlines Optimal Pediatric Chest Wall Rhabdomyosarcoma Care

November 13th 2025

More News

© 2025 MJH Life Sciences
AJMC®
All rights reserved.